Mequitazine

美喹他嗪

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameMequitazine
Drug Alias NameReleaseVigiganPrimalanHistacoidMetaplexan +[11
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsUrticariaPruritusEczema +[8
Global Approved IndicationsUrticariaPruritusEczema +[6
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
China Registration ClassN/A

Develop Information

Active CompaniesAsahi Kasei Pharma Corp
Active IndicationsUrticariaPruritusEczema +[8
Inactive IndicationsN/A

Other Information

ATC CodeR06AD07